<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896911401387</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896911401387</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Vulvar Encapsulated Solid Papillary Carcinoma With Neuroendocrine Differentiation: A Case Report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname><given-names>Cunxian</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896911401387">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Quddus</surname><given-names>M. Ruhul</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911401387">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sung</surname><given-names>C. James</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911401387">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Moore</surname><given-names>Richard G.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1066896911401387">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lawrence</surname><given-names>W. Dwayne</given-names></name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-1066896911401387">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896911401387"><label>1</label>Department of Pathology and Laboratory Medicine, Women &amp; Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, Rhode Island</aff>
<aff id="aff2-1066896911401387"><label>2</label>Program in Women’s Oncology, Department of Obstetrics and Gynecology, Women &amp; Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, Rhode Island</aff>
<author-notes>
<corresp id="corresp1-1066896911401387">Cunxian Zhang, MD, PhD, Department of Pathology, Women &amp; Infants Hospital, 101 Dudley Street, Providence, RI 02905, USA Email: <email>czhang@wihri.org</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>100</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>A 40-year-old woman underwent excision of a painless left vulvar mass. The specimen showed a well-circumscribed mass measuring 3.5 × 2.7 × 2.5 cm. Microscopic examination exhibited an encapsulated neoplasm with a solid and papillary growth pattern. The tumor cells were oval to columnar and showed moderate nuclear atypia. No capsular invasion was identified. Immunonegativity for calponin and p63 confirmed the absence of myoepithelial cells either within or at the periphery of the tumor. The tumor was immunopositive for gross cystic disease fluid protein 15, synaptophysin, and chromogranin. The histologic and immunohistochemical characteristics were consistent with an encapsulated solid papillary carcinoma with neuroendocrine differentiation. The patient has been free of disease for 4 years after surgery. This is the first report of a vulvar encapsulated solid papillary carcinoma with neuroendocrine differentiation. Correct diagnosis is imperative because of the distinct biologic behavior of the tumor.</p>
</abstract>
<kwd-group>
<kwd>vulva</kwd>
<kwd>carcinoma</kwd>
<kwd>encapsulated</kwd>
<kwd>papillary</kwd>
<kwd>solid</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896911401387" sec-type="intro">
<title>Introduction</title>
<p>Vulvar cancer represents the fourth most common gynecologic cancer (following cancers of the endometrium, ovary, and uterine cervix) and accounts for about 4% of malignancies in the female genital tract.<sup><xref ref-type="bibr" rid="bibr1-1066896911401387">1</xref></sup> About 95% of primary vulvar cancers are squamous cell type.<sup><xref ref-type="bibr" rid="bibr2-1066896911401387">2</xref>,<xref ref-type="bibr" rid="bibr3-1066896911401387">3</xref></sup> The remaining vulvar cancers include adenocarcinoma and basal cell carcinoma. Vulvar cancers usually occur in older women, with a mean age of 57.2 years.<sup><xref ref-type="bibr" rid="bibr4-1066896911401387">4</xref></sup> We report a rare case of vulvar encapsulated solid papillary carcinoma with neuroendocrine differentiation in a young woman.</p>
</sec>
<sec id="section2-1066896911401387" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>A 40-year-old Caucasian female patient, gravida 4 and para 2, was referred to the Women’s Oncology clinic of our institution for evaluation of a painless left vulvar mass noticed by the patient 3 months prior to presentation. The patient denied any history of a Bartholin gland cyst or abscess or sexually transmitted diseases. Her family history was significant for prostate cancer in her father and breast cancer in her paternal grandmother. Physical examination revealed in the left vulva a smooth mobile soft cystic mass clinically consistent with a Bartholin cyst. By magnetic resonance imaging, the mass was identified in the left labia majora along the left side of the vaginal vestibule. No other abnormalities were found. The patient underwent a wide local excision of the vulvar mass.</p>
<p>Gross examination of the specimen showed a well-circumscribed mass measuring 3.5 × 2.7 × 2.5 cm. The cut surfaces were soft, predominantly solid, and focally cystic. Microscopic examination exhibited an encapsulated tumor with a solid and papillary growth pattern (<xref ref-type="fig" rid="fig1-1066896911401387">Figure 1</xref>). The papillae displayed fibrovascular cores lined by one to several layers of oval to columnar epithelial cells with abundant eosinophilic cytoplasm (<xref ref-type="fig" rid="fig2-1066896911401387">Figure 2</xref>). The nuclei were hyperchromatic and showed moderate atypia. The chromatin was evenly distributed and exhibited a somewhat salt-pepper-like pattern. The mitotic index was in the range of 0 to 1 per 10 high power fields. The tumor showed focal psammoma bodies. Scattered benign Bartholin glands were seen in the tumor capsule and adjacent tissue (<xref ref-type="fig" rid="fig3-1066896911401387">Figure 3</xref>), but no tumor invasion of capsule was identified. Immunonegativity for calponin and p63 confirmed the absence of myoepithelial cells within or at the periphery of the tumor (<xref ref-type="fig" rid="fig4-1066896911401387">Figure 4</xref>). The tumor was immunopositive for gross cystic disease fluid protein 15 (<xref ref-type="fig" rid="fig5-1066896911401387">Figure 5</xref>), synaptophysin, and chromogranin (<xref ref-type="fig" rid="fig6-1066896911401387">Figure 6</xref>). It was immunonegative for estrogen receptor, progesterone receptor, and Her2/neu. Focal tumor cells showed intracellular mucicarmine positivity. The findings were consistent with an encapsulated solid papillary carcinoma with neuroendocrine differentiation.</p>
<fig id="fig1-1066896911401387" position="float">
<label>Figure 1.</label>
<caption>
<p>Scan view of slide shows an encapsulated tumor (hematoxylin and eosin; original magnification: scan)</p>
</caption>
<graphic xlink:href="10.1177_1066896911401387-fig1.tif"/>
</fig>
<fig id="fig2-1066896911401387" position="float">
<label>Figure 2.</label>
<caption>
<p>Microscopic examination of tumor exhibits a solid and papillary growth pattern; at higher magnification (insert), the cells are oval, contain abundant eosinophilic cytoplasm, and show round to oval nuclei with hyperchromasia (hematoxylin and eosin; original magnifications: 100× for background picture and 400× for insert)</p>
</caption>
<graphic xlink:href="10.1177_1066896911401387-fig2.tif"/>
</fig>
<fig id="fig3-1066896911401387" position="float">
<label>Figure 3.</label>
<caption>
<p>The right upper corner shows tumor (short thick arrow), and the left lower part shows capsule with Bartholin glands (long thin arrow) (hematoxylin and eosin; original magnification: 100×)</p>
</caption>
<graphic xlink:href="10.1177_1066896911401387-fig3.tif"/>
</fig>
<fig id="fig4-1066896911401387" position="float">
<label>Figure 4.</label>
<caption>
<p>Negative immunoreaction for smooth muscle myosin heavy chain indicates absence of myoepithelial cells either within or at the periphery of tumor. Note the positive internal controls in vessels (arrow) (hematoxylin and eosin; original magnification: 100×)</p>
</caption>
<graphic xlink:href="10.1177_1066896911401387-fig4.tif"/>
</fig>
<fig id="fig5-1066896911401387" position="float">
<label>Figure 5.</label>
<caption>
<p>The tumor is diffusely and strongly immunopositive for gross cystic disease fluid protein 15, suggesting derivation from supernumerary breast tissue (original magnification: 400×)</p>
</caption>
<graphic xlink:href="10.1177_1066896911401387-fig5.tif"/>
</fig>
<fig id="fig6-1066896911401387" position="float">
<label>Figure 6.</label>
<caption>
<p>Immunohistochemistry shows strong positivity for chromogranin (original magnification: 400×)</p>
</caption>
<graphic xlink:href="10.1177_1066896911401387-fig6.tif"/>
</fig>
<p>Although reexcision was recommended due to close surgical margins, the patient opted for close follow-up without further treatment. She has been free of tumor for 4 years after surgery.</p>
</sec>
<sec id="section3-1066896911401387" sec-type="discussion">
<title>Discussion</title>
<p>To our knowledge, this is the first report of an encapsulated solid papillary carcinoma of the vulva. A possible derivation of tumor from the Bartholin glands may be suggested by the tumor location along the left side of the vaginal vestibule where the normal Bartholin glands are centered. This possibility is supported by the presence of scattered Bartholin glands in the tumor capsule and adjacent tissue. Alternatively, the tumor may have arisen from the specialized anogenital mammary-like glands that can be normally found in the interlabial sulcus, in the medial aspects of the labia majora, and in the perineum around the anus. Anogenital mammary-like glands are morphologically similar to the breast tissue. They are known to be capable of developing into various benign and malignant lesions that can be seen in the breast. Benign lesions include fibrocystic changes, papillary hidradenoma, and fibroadenoma.<sup><xref ref-type="bibr" rid="bibr5-1066896911401387">5</xref></sup> The majority of carcinomas arising from the anogenital mammary-like glands exhibit an infiltrating ductal or lobular pattern.<sup><xref ref-type="bibr" rid="bibr6-1066896911401387">6</xref><xref ref-type="bibr" rid="bibr7-1066896911401387"/>-<xref ref-type="bibr" rid="bibr8-1066896911401387">8</xref></sup> In our case, the origin of tumor from the anogenital mammary-like glands is possible because the same type of tumor can be seen in the breast. This possibility is supported by an immunopositivity for gross cystic disease fluid protein 15, a marker for mammary and mammary-like glandular tissue.</p>
<p>Similar tumor in the breast was previously named intracystic papillary carcinoma and was traditionally considered a variant of ductal carcinoma in situ. However, whether the tumor is in situ or invasive has recently become a subject of debate. While some investigators propose that such tumors are carcinomas with “expansile” or “pushing” invasion based on immunohistochemical studies showing absence of myoepithelial cells at tumor periphery,<sup><xref ref-type="bibr" rid="bibr9-1066896911401387">9</xref>,<xref ref-type="bibr" rid="bibr10-1066896911401387">10</xref></sup> other authors suggest that these tumors are in situ carcinomas because they are surrounded by type IV collagen.<sup><xref ref-type="bibr" rid="bibr11-1066896911401387">11</xref></sup> Regardless of the controversies on the histologic invasive status of the tumor, studies have shown that the clinical behavior of these tumors is similar to ductal carcinoma in situ.<sup><xref ref-type="bibr" rid="bibr9-1066896911401387">9</xref><xref ref-type="bibr" rid="bibr10-1066896911401387"/>-<xref ref-type="bibr" rid="bibr11-1066896911401387">11</xref></sup> Thus, most investigators now prefer the term <italic>encapsulated papillary carcinoma</italic> to emphasize the encapsulation of tumor and to recognize the uncertainty of invasion. The tumor in our patient resembles the so-called encapsulated papillary carcinoma of the breast in that it is encapsulated, shows a solid papillary cystic architecture, and lacks myoepithelial cells within and at the periphery of the tumor.</p>
<p>The tumor in our case was negative for estrogen and progesterone receptors. This is not surprising since encapsulated papillary carcinomas of the breast can also be negative for hormone receptors.<sup><xref ref-type="bibr" rid="bibr11-1066896911401387">11</xref></sup> A neuroendocrine differentiation was indicated by a diffuse synaptophysin and chromogranin immunopositivity in the tumor of our patient. Although neuroendocrine differentiation in many cancers is associated with a poor prognosis,<sup><xref ref-type="bibr" rid="bibr12-1066896911401387">12</xref>,<xref ref-type="bibr" rid="bibr13-1066896911401387">13</xref></sup> it may not influence the biologic behavior of encapsulated solid papillary carcinoma of the breast and vulva. Kanbayashi et al<sup><xref ref-type="bibr" rid="bibr14-1066896911401387">14</xref></sup> reported a favorable outcome in 2 patients with encapsulated solid papillary carcinoma of the breast with neuroendocrine differentiation. Our case demonstrated an excellent prognosis in vulvar encapsulated solid papillary carcinoma with neuroendocrine differentiation.</p>
<p>Encapsulated solid papillary carcinoma of the vulva should be distinguished from papillary hidradenoma because the former is a malignant tumor whereas the latter is benign. Although both tumors show encapsulation and a papillary growth pattern, they differ in cellular details. Whereas papillary hidradenoma is composed of epithelial and myoepithelial cells lining complex delicate fibrovascular branching papillae, encapsulated solid papillary carcinoma lacks myoepithelial component. The cells in papillary hidradenoma are usually bland, but those in encapsulated papillary carcinoma show a significant nuclear atypia. Encapsulated papillary carcinoma of the vulva should also be differentiated from invasive adenocarcinoma because the latter carries a higher risk of metastasis and is associated with a worse prognosis. In contrast to encapsulated solid papillary carcinoma that shows a capsule and a complex papillary architecture, invasive adenocarcinoma lacks a capsule and shows malignant glands infiltrating the stroma in a haphazard fashion. The differential diagnoses should also include metastatic carcinoma from the breast, most of which show a histologic pattern of invasive ductal or lobular carcinoma.<sup><xref ref-type="bibr" rid="bibr15-1066896911401387">15</xref></sup> Our case is unlikely a metastatic breast carcinoma since the tumor was encapsulated and did not show an infiltrating pattern. Also, our patient did not have a history of breast carcinoma.</p>
<p>Close follow-up did not reveal any evidence of recurrent disease in our patient after resection of tumor 4 years ago. Our case suggests that local excision with negative margins may be an adequate treatment for vulvar encapsulated solid papillary carcinoma without stromal invasion in a thoroughly sampled specimen. This is in contrast to vulvar invasive carcinomas that frequently require regional lymph node sampling to rule out metastasis. In addition, patients with invasive carcinomas may need postoperative radiation, chemotherapy, or both based on extent of tumor, distance of resection margins relative to tumor, and status of metastasis.</p>
<p>In summary, vulvar encapsulated solid papillary carcinoma with neuroendocrine differentiation is a rare tumor. Correct diagnosis is important because of its distinct biological behavior.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896911401387">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jemal</surname><given-names>A</given-names></name>
<name><surname>Siegel</surname><given-names>R</given-names></name>
<name><surname>Ward</surname><given-names>E</given-names></name>
<name><surname>Hao</surname><given-names>Y</given-names></name>
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Thun</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Cancer statistics, 2009</article-title>. <source>CA Cancer J Clin</source>. <year>2009</year>;<volume>59</volume>:<fpage>225</fpage>-<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr2-1066896911401387">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kosary</surname><given-names>CL</given-names></name>
</person-group>. <article-title>FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina</article-title>. <source>Semin Surg Oncol</source>. <year>1994</year>;<volume>10</volume>:<fpage>31</fpage>-<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr3-1066896911401387">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shepherd</surname><given-names>J</given-names></name>
<name><surname>Sideri</surname><given-names>M</given-names></name>
<name><surname>Benedet</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Carcinoma of the vulva</article-title>. <source>J Epidemiol Biostat</source>. <year>1998</year>;<volume>3</volume>:<fpage>111</fpage>-<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr4-1066896911401387">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>HN</given-names></name>
<name><surname>Lee</surname><given-names>KH</given-names></name>
<name><surname>Lee</surname><given-names>CW</given-names></name>
<name><surname>Kim</surname><given-names>CJ</given-names></name>
<name><surname>Park</surname><given-names>JS</given-names></name>
<name><surname>Namkoong</surname><given-names>SE</given-names></name>
</person-group>. <article-title>A clinicopathologic study of vulva cancer</article-title>. <source>Korean J Gynecol Oncol Colposc</source>. <year>2004</year>;<volume>15</volume>:<fpage>213</fpage>-<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr5-1066896911401387">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van der Putte</surname><given-names>SC</given-names></name>
</person-group>. <article-title>Mammary-like glands of the vulva and their disorders</article-title>. <source>Int J Gynecol Pathol</source>. <year>1994</year>;<volume>13</volume>:<fpage>150</fpage>-<lpage>160</lpage>.</citation>
</ref>
<ref id="bibr6-1066896911401387">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lopes</surname><given-names>G</given-names></name>
<name><surname>DeCesare</surname><given-names>T</given-names></name>
<name><surname>Ghurani</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Primary ectopic breast cancer presenting as a vulvar mass</article-title>. <source>Clin Breast Cancer</source>. <year>2006</year>;<volume>7</volume>:<fpage>278</fpage>-<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr7-1066896911401387">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>North</surname><given-names>J</given-names></name>
<name><surname>Perez</surname><given-names>D</given-names></name>
<name><surname>Fentiman</surname><given-names>G</given-names></name>
<name><surname>Sykes</surname><given-names>P</given-names></name>
<name><surname>Dempster</surname><given-names>A</given-names></name>
<name><surname>Pearse</surname><given-names>M</given-names></name>
</person-group>. <article-title>Primary breast cancer of the vulva: case report and literature review</article-title>. <source>Aust N Z J Obstet Gynaecol</source>. <year>2007</year>;<volume>47</volume>:<fpage>77</fpage>-<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr8-1066896911401387">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fracchioli</surname><given-names>S</given-names></name>
<name><surname>Puopolo</surname><given-names>M</given-names></name>
<name><surname>De La Longrais</surname><given-names>IA</given-names></name>
<etal/>
</person-group>. <article-title>Primary “breast-like” cancer of the vulva: a case report and critical review of the literature</article-title>. <source>Int J Gynecol Cancer</source>. <year>2006</year>;<volume>16</volume>:<fpage>423</fpage>-<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr9-1066896911401387">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Collins</surname><given-names>LC</given-names></name>
<name><surname>Carlo</surname><given-names>VP</given-names></name>
<name><surname>Hwang</surname><given-names>H</given-names></name>
<name><surname>Barry</surname><given-names>TS</given-names></name>
<name><surname>Gown</surname><given-names>AM</given-names></name>
<name><surname>Schnitt</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers</article-title>. <source>Am J Surg Pathol</source>. <year>2006</year>;<volume>30</volume>:<fpage>1002</fpage>-<lpage>1007</lpage>.</citation>
</ref>
<ref id="bibr10-1066896911401387">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hill</surname><given-names>CB</given-names></name>
<name><surname>Yeh</surname><given-names>IT</given-names></name>
</person-group>. <article-title>Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas</article-title>. <source>Am J Clin Pathol</source>. <year>2005</year>;<volume>123</volume>:<fpage>36</fpage>-<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr11-1066896911401387">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Esposito</surname><given-names>NN</given-names></name>
<name><surname>Dabbs</surname><given-names>DJ</given-names></name>
<name><surname>Bhargava</surname><given-names>R</given-names></name>
</person-group>. <article-title>Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases</article-title>. <source>Am J Clin Pathol</source>. <year>2009</year>;<volume>131</volume>:<fpage>228</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr12-1066896911401387">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weinstein</surname><given-names>MH</given-names></name>
<name><surname>Partin</surname><given-names>AW</given-names></name>
<name><surname>Veltri</surname><given-names>RW</given-names></name>
<name><surname>Epstein</surname><given-names>JI</given-names></name>
</person-group>. <article-title>Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy</article-title>. <source>Hum Pathol</source>. <year>1996</year>;<volume>27</volume>:<fpage>683</fpage>-<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr13-1066896911401387">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hiroshima</surname><given-names>K</given-names></name>
<name><surname>Iyoda</surname><given-names>A</given-names></name>
<name><surname>Shibuya</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung</article-title>. <source>Ann Thorac Surg</source>. <year>2002</year>;<volume>73</volume>:<fpage>1732</fpage>-<lpage>1735</lpage>.</citation>
</ref>
<ref id="bibr14-1066896911401387">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanbayashi</surname><given-names>C</given-names></name>
<name><surname>Oka</surname><given-names>K</given-names></name>
<name><surname>Hakozaki</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Solid papillary carcinoma of the breast: report of two cases</article-title>. <source>Ultrastruct Pathol</source>. <year>2001</year>;<volume>25</volume>:<fpage>147</fpage>-<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr15-1066896911401387">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sheen-Chen</surname><given-names>SM</given-names></name>
<name><surname>Eng</surname><given-names>HL</given-names></name>
<name><surname>Huang</surname><given-names>CC</given-names></name>
</person-group>. <article-title>Breast cancer metastatic to the vulva</article-title>. <source>Gynecol Oncol</source>. <year>2004</year>;<volume>94</volume>:<fpage>858</fpage>-<lpage>860</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>